Arcus Biosciences' cancer drug candidate, quemliclustat, earns FDA orphan drug status, ensuring incentives and exclusivity.

Learn how first-line antiepileptic drugs, personalized care, and lifestyle changes work together to manage generalized ...

Elon Musk isn’t new to controversy, but this time the firestorm came in the form of a drug test. After weeks of speculation following a New York Times report accusing him of heavy ketamine and drug ...

Polyrizon initiates preclinical studies on intranasal Benzodiazepines for treating acute seizures, aiming to enhance emergency response.

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Status Epilepticus market or expected to get launched during the study period.

WebMD explains the various drugs used to treat epilepsy and seizures, including side effects.

Stopping Status Epilepticus UVA’s new trial builds on its previous treatment trial, which provided the first definitive answers about how and when three drugs commonly used to treat seizures should be ...

The treatment of status epilepticus (SE) has changed little in the last 20 years, largely because of the high risks and costs of new drug development for SE. Moreover, SE poses specific challenges to ...

The Status Epilepticus drugs in development market research report provides comprehensive information on the therapeutics under development for Status Epilepticus, complete with analysis by stage of ...

"Marinus Pharmaceuticals reports data from refractory status epilepticus drug trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.